+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Viral Vector Manufacturing Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Lentiviral Vectors), Disease (Cancer, Genetic Disorders, Infectious Diseases), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5613111
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Viral Vector Manufacturing Market size was estimated at USD 1.05 billion in 2023, USD 1.25 billion in 2024, and is expected to grow at a CAGR of 19.11% to reach USD 3.59 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Viral Vector Manufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Viral Vector Manufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Viral Vector Manufacturing Market, highlighting leading vendors and their innovative profiles. These include ABL Inc., Beckman Coulter, Inc., Biovian Oy, Charles River Laboratories International, Inc., Cytiva, Finvector, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Genezen Laboratories, Inc., Lonza Group Ltd., Merck KGaA, Novartis AG, Sanofi SA, Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and uniQure N.V.

Market Segmentation & Coverage

This research report categorizes the Viral Vector Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Adeno-associated Viral Vectors
    • Adenoviral Vectors
    • Lentiviral Vectors
    • Retroviral Vectors
  • Disease
    • Cancer
    • Genetic Disorders
    • Infectious Diseases
  • Application
    • Gene Therapy
    • Vaccinology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Viral Vector Manufacturing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Viral Vector Manufacturing Market?
  3. What are the technology trends and regulatory frameworks in the Viral Vector Manufacturing Market?
  4. What is the market share of the leading vendors in the Viral Vector Manufacturing Market?
  5. Which modes and strategic moves are suitable for entering the Viral Vector Manufacturing Market?

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Viral Vector Manufacturing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in prevalence of disease such as cancer, metabolic diseases, heart defects
5.1.1.2. Growth in development of gene therapy
5.1.1.3. Rise in registration of clinical trials for viral vector-mediated gene therapy
5.1.2. Restraints
5.1.2.1. Limited shelf-life of viral vector
5.1.3. Opportunities
5.1.3.1. High focus on yield optimization
5.1.3.2. Technology innovation in viral vector manufacturing
5.1.4. Challenges
5.1.4.1. Strict regulatory guidance for viral vector manufacturing
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Viral Vector Manufacturing Market, by Type
6.1. Introduction
6.2. Adeno-associated Viral Vectors
6.3. Adenoviral Vectors
6.4. Lentiviral Vectors
6.5. Retroviral Vectors
7. Viral Vector Manufacturing Market, by Disease
7.1. Introduction
7.2. Cancer
7.3. Genetic Disorders
7.4. Infectious Diseases
8. Viral Vector Manufacturing Market, by Application
8.1. Introduction
8.2. Gene Therapy
8.3. Vaccinology
9. Americas Viral Vector Manufacturing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Viral Vector Manufacturing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Viral Vector Manufacturing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. ABL Inc.
13.1.2. Beckman Coulter, Inc.
13.1.3. Biovian Oy
13.1.4. Charles River Laboratories International, Inc.
13.1.5. Cytiva
13.1.6. Finvector
13.1.7. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
13.1.8. Genezen Laboratories, Inc.
13.1.9. Lonza Group Ltd.
13.1.10. Merck KGaA
13.1.11. Novartis AG
13.1.12. Sanofi SA
13.1.13. Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
13.1.14. Thermo Fisher Scientific Inc.
13.1.15. uniQure N.V.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. VIRAL VECTOR MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. VIRAL VECTOR MANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VIRAL VECTOR MANUFACTURING MARKET DYNAMICS
FIGURE 7. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 10. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. VIRAL VECTOR MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. VIRAL VECTOR MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. VIRAL VECTOR MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RETROVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 11. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 29. CANADA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. CHINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 46. CHINA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. INDIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 49. INDIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. JAPAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. THAILAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. EGYPT VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. FINLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. FRANCE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. GERMANY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ITALY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 101. ITALY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NORWAY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. POLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 113. POLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. QATAR VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 116. QATAR VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SPAIN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. TURKEY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. VIRAL VECTOR MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. VIRAL VECTOR MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. VIRAL VECTOR MANUFACTURING MARKET LICENSE & PRICING

Companies Mentioned

  • ABL Inc.
  • Beckman Coulter, Inc.
  • Biovian Oy
  • Charles River Laboratories International, Inc.
  • Cytiva
  • Finvector
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • Genezen Laboratories, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Novartis AG
  • Sanofi SA
  • Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • uniQure N.V.

Methodology

Loading
LOADING...

Table Information